Tweets
We should aim for early treatment and good retention in ax-SpA to prevent structural evolution. >12 months of TNFi treatment in the previous 2 years associated w/ ⬇️ radiographic progression of SIJ in r- and nr-axSpA in GESPIC, #Abst0174 @RheumNow #ACR21 https://t.co/2V1q4dUwFO https://t.co/lxQU4zAP1I
Aurelie Najm @AurelieRheumo ( View Tweet )
4 years 9 months ago
Retrospective French study found adding JAKi may be helpful in refractory AOSD. No complete response noted and no beneficial effect as monotherapy. Possible difference between JAKi? Abs 0195 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/J8kLJpJ39o https://t.co/aVsfCQ8CyV
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 9 months ago
Our latest article on outcomes of patients with vasculitis and PMR and COVID-19 published in @TheLancetRheum . @rheum_covid project with co-leads @SattuiSEMD and @EBRheum . https://t.co/8NTAafdYRA
Richard Conway @RichardPAConway ( View Tweet )
4 years 9 months ago
#Fatigue is common in pts w/ #PsA- what is the impact on short-term disability?
Study of ~1200 pts finds greater annual short-term disability in pts with PsA & fatigue than w/o fatigue. Impact on QoL, work & socioeconomic costs.
@RheumNow #ACR21 Abs#0239
https://t.co/9yNBOovm2L https://t.co/l4tn0TSld1
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 9 months ago
📌Pre-Test Probability in GCA
ESR/CRP can be normal:
~10% of pts at diagnosis
-20-40% at time or relapse
#ACR21 #ACRAmbassador #RheumTwitter https://t.co/kenaD31pYa
Nina Couette @RheumDr_Nina ( View Tweet )
4 years 9 months ago
Machine learning predicted lupus nephritis in #SLE patients in real world data #ACR21 @RheumNow #abst0324 https://t.co/67HBT7F2GO
Bella Mehta @bella_mehta ( View Tweet )
4 years 9 months ago
Dr Doliner @zach_wallace_md on ILD in AAV. ILD in 13% - of which 76% fibrotic. UIP most common. Most MPO+, but also rarely seen with PR3+. 47% ⬆️ risk of death. Abstr#0430 #ACR21 @RheumNow https://t.co/6MnxqW92bz
Richard Conway @RichardPAConway ( View Tweet )
4 years 9 months ago
Dr Preger report 9 novel aminoacyl tRNA synthetases in IIM patients. May these allow us to spare more patients biopsy? Abstr#0001 #ACR21 @RheumNow https://t.co/ikNXCEOeuj
Richard Conway @RichardPAConway ( View Tweet )
4 years 9 months ago
Don't wait!
DR. Petri wants us to change paradigm of how we treat aggressive lupus nephritis: early, aggressive, and multimodal. Does not matter if you add on VCS or BLMB, just don't treat LN with MMF monotherapy.
#ACR21 #GreatDebate @rheumnow https://t.co/ebSiic095h
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 9 months ago
#Flu vaccine coverage remains low in patients with #rheumatoidarthritis.
Results from @earlyarthritis Abs#0141
https://t.co/DoZl5xyq2Q
How can we increase vaccine uptake in our patients?
@RheumNow https://t.co/nldA63EcVW
Mrinalini Dey @DrMiniDey ( View Tweet )
4 years 9 months ago
#ACR2021
Remember, one reason belimumab is so safe is that it does not completely deplete B cells. Particularly important in times of COVID19.
Dr. Petri #GreatDebate @RheumNow
Pedro Castillo @_Castillo_Pedro ( View Tweet )
4 years 9 months ago
Dr O'Brien on co-existent AAV and RA. Not something I'm used to seeing, but maybe we need to think about it more? 25 cases with RA+AAV, 52 with RA + ANCA but no AAV, not sure what the denominator is here though. Abstr#0428 #ACR21 @RheumNow @profgayecunnane https://t.co/fN3BRpc7UJ
Richard Conway @RichardPAConway ( View Tweet )
4 years 9 months ago
